- Home
- FIGS vs INVA Comparison
FIGS vs INVA Comparison
Compare FIGS & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FIGS | INVA |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2021 | 2004 |
Fundamental Metrics
Financial Performance| Metric | FIGS | INVA |
|---|---|---|
| Price | $11.93 | $19.57 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $9.60 | ★ $36.80 |
| AVG Volume (30 Days) | ★ 2.3M | 959.7K |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.65 | 53.96 |
| EPS | 0.11 | ★ 1.52 |
| Revenue | ★ $581,034,000.00 | $388,521,000.00 |
| Revenue This Year | $9.08 | $13.23 |
| Revenue Next Year | $5.07 | $8.58 |
| P/E Ratio | $110.60 | ★ $12.66 |
| Revenue Growth | 5.90 | ★ 10.14 |
| 52 Week Low | $3.57 | $16.52 |
| 52 Week High | $12.35 | $22.76 |
Technical Indicators
Market Signals| Indicator | FIGS | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 63.79 | 41.38 |
| Support Level | $11.02 | $19.26 |
| Resistance Level | $11.79 | $20.23 |
| Average True Range (ATR) | 0.41 | 0.48 |
| MACD | -0.12 | -0.05 |
| Stochastic Oscillator | 69.65 | 30.69 |
Price Performance
Historical ComparisonAbout FIGS FIGS Inc.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.